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preliminary	 experiments	 with	 a	 partial	 cDNA,	 which	
blocked	the	proliferation	of	endothelial	cells,	the	novel	TNF	
ligand	 was	 named	 vascular	 endothelial	 growth	 inhibitor	











is	 also	 expressed	 in	 tissue	 macrophages,	 lamina	 propria	 	
T	cells	and	plasma	cells,	FcgR-activated	peripheral	blood	
mononuclear	 cells	 (PBMC),	 and	 monocyte-derived	 den-
dritic	cells	(26–29).	TL1A	is	the	only	known	ligand	for	the	
death	receptor	DR3	(TNFRSF12)	(21).	DR3	was	shown	to	
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inflammatory	 diseases,	 such	 as	 renal	 inflammation	 (25),	







has	 an	 autoimmune	 component	 and	 is	 considered	 as	 an	 	
inflammatory	disease	(44).












































Cell Proliferation and Apoptosis
Cell	 proliferation	 was	 assayed	 using	 the	 5-bromo-2′-




































quence	 of	TL1A	 (GenBank	 NM_005118).	The	 resulting	
vector	was	used	to	introduce	the	TL1A	coding	sequence	 DIFFERENTIAL ECTODOMAIN SHEDDING OF TL1A 1167
into	pLenti6/UbC/V5-DEST	by	recombination	to	generate	
the	 transfer	 vector	 pLenti6/UbC/TL1A	 (see	 Invitrogen’s	 	





pLKO.1-TRC	 short-hairpin	 vector	 from	 Addgene/Open	
Biosystems	(Epsom,	UK).	Following	sequences	within	the	
TL1A,	mRNAs	were	chosen	as	target:	pLKO1	within	the	 	
3′	 noncoding	 region	 of	 TL1A	 (5′-GAGGAGACTGAGT-
GATTAA-3′)	 and	 pLKO99	 within	 the	 coding	 region	
(5′-GCCATGTTCTCC	 TTGCAAGAA-3′).	The	short	hair-
pin	RNA	for	pLKO1	was	designed	using	the	Dharmacon	
siDESIGN	 center	 (for	 cloning	 procedure,	 refer	 to	 the	
pLKO.1-TRC	 Cloning	 Vector	 manual	 from	 Addgene).	
Transfer	vector	pLKO99	was	obtained	from	Open	Biosys-
tems.	As	a	control	the	pLKO.1-TRC	control	vector	(Add-
































Reverse Transcriptase–Polymerase Chain Reaction
For	 RT-PCR,	 the	 mRNA	 of	 cells	 was	 isolated	 using	 	
the	RNeasy	mini	kit	(Cat.	No.	74104;	Qiagen,	Vienna,	
Austria)	 and	 reverse	 transcribed	 into	 cDNA	 using	 the	
transcriptor	 first-strand	 cDNA	 synthesis	 kit	 (Cat.	 No.	
04896866001;	Roche),	following	procedure	A	of	the	pro-








VEGI-192	 (fw	 5′-TTCAGTCACCCTTTGTCTC-3′	 rev	
5′-AGGCCTAGTTCATGTTCC-3′).
Real-Time-quantitative-PCR
Isolation	 of	 mRNA	 and	 cDNA	 generation	 was	 per-
formed	like	described	previously.	To	quantify	the	amount	


















(Institute	 for	 Genomics	 and	 Bioinformatics,	 Graz,	Austria,	






cording	 to	 the	 manufacturer’s	 manual,	 cell	 lysate	 or	





N-	 and	 O-linked	 oligosaccharides,	 N-glycosidase	 F,	 a2-
3,6,8,9-neuraminidase,	endo-a-N-acetylgalactosaminidase,	





Western Blot of Cell Lysates and Supernatants
TL1A-transfected	U-2OS	cells	were	grown	in	six-well	






















anti-human	 TL1A/TNFSF15	 antibody	 (Cat.	 No.	AF744;	
R&D	Systems,	Biomedica,	Vienna,	Austria)	and	mouse	




To	 introduce	 expression	 plasmids	 into	 HUVEC,	 the	
HUVEC	 nucleofector	 kit	 (Cat.	 No.	 VPB-1002)	 from	
AMAXA,	Lonza,	Verviers,	Belgium	was	used.	The	method	
was	 performed	 like	 described	 in	 the	 manufacturer’s	
protocol.




















primer	 pair	 (fw	 5′-TATACATATGCTGCACTGGGAA-
CATGAACTA-3′)	 and	 (rev	 5′-TATAGGATCCCTATAG-
TAAGAAGGCTCCAAAGAAGGT-3′)	 was	 used.	 For	
TL1AV84-L251,	(fw	5′-TATACATATGGTTTATGCACCTCT-







































containing	 fractions	 were	 pooled	 and	 dialyzed	 against	 	 DIFFERENTIAL ECTODOMAIN SHEDDING OF TL1A 1169
PBS.	Concentration	of	TL1A	protein	was	assessed	by	mea-
surement	at	optical	density	of	280	nm.























TL1A Is the Main Isoform in HUVEC
In	 addition	 to	 canonical	 TL1A	 (VEGI-251),	 two	 iso-
forms,	 referred	 to	 as	VEGI-174	 and	VEGI-192,	 respec-
tively,	were	described	that	are	believed	to	be	generated	by	
differential	splicing	(23).	To	analyze	the	major	isoforms	in	















tion	 cycles	 (data	 not	 shown).	The	 identity	 of	VEGI-174	 	
was	verified	by	sequencing,	and	a	lentiviral	vector	for	the	







protein	 band	 of	 an	 apparent	 molecular	 weight	 (MW)	 of	 	
22	 kDa	 was	 observed,	 which	 probably	 corresponds	 to	
VEGI-174.	When	the	supernatant	of	U-2OS	cells	overex-
























gel	electrophoresis	for	higher	resolution	and	analyzed	by	Western	blot	using	anti-TL1A	antibody. DIFFERENTIAL ECTODOMAIN SHEDDING OF TL1A 1171
TL1A/VEGI-251	(Figure	1B,	right).	Based	on	these	find-
ings,	VEGI-174	was	not	further	investigated.
Transmembrane Location and Ectodomain Shedding  
of TL1A
To	determine	the	subcellular	localization	of	TL1A	in	en-
dothelial	 cells,	 HUVEC	 were	 transiently	 transfected	 by	
AMAXA	 with	 a	 TL1A	 expression	 vector	 (pcDNA3.1/
TL1A).	Expression	of	TL1A	was	verified	by	Western	blot	
(Figure	 2A,	 left).	 Subcellular	 localization	 of	 TL1A	 was	
probed	by	indirect	immunofluorescence	using	two	fixation	






is	 proteolytically	 cleaved	 and	 thereby	 secreted	 into	 the	 	
extracellular	space	(50),	a	process	called	ectodomain	shed-
ding.	To	 test	 whether	 such	 mechanism	 applies	 to	TL1A,	 	
U-2OS	cells	and	HUVEC	were	transiently	transfected	with	































ding	 (54).	To	 address	 the	 question	 if	TL1A	 ectodomain	
shedding	can	also	be	activated	via	this	pathway,	cells	were	









































































































fore	 represent	 CEP	 that	 are	 already	 near	 senescence.	 	















cells	 by	 about	 20%	 compared	 with	 CEP	 overexpressing	
green	fluorescent	protein.









































apoptotic	 phenotype	 obtained	 by	 ectopic	 expression	 of	
TL1A	(see	previously,	Figure	4E).	However,	the	detectable	
concentration	of	TL1A	in	conditioned	medium	was	very	














microscopy.	Three	experiments	were	performed	and	representative	pictures	are	shown. DIFFERENTIAL ECTODOMAIN SHEDDING OF TL1A 1175
In	an	alternative	strategy	to	test	the	role	of	extracellular	
































the	 literature	 that	 recombinant	 TL1AL72-L251	 showed	 no	














with	 IL-12/IL-18	 (Figure	 5D,	 left).	 Within	 the	 PBMC	 	
pool,	the	NK	cells	was	the	predominant	population	of	cells	





































with	 a	 modified	 guanidinium	 thiocyanate	 method	 (61),	
which	is	known	to	yield	considerable	amounts	of	genomic	
DNA	contamination	(62).	BLASTing	the	putative	mRNA	of	
VEGI-174	 (GenBank	AF039390)	 against	 the	 human	 ge-
nome	revealed	that	the	putative	mRNA	is	coded	by	a	contin-
uous	 genomic	 region	 (data	 not	 shown).	 Therefore,	 it	 is	
highly	likely	that	the	VEGI-174	DNA	clone	derived	from	
genomic	DNA	rather	than	cDNA.
TL1A is a Transmembrane Protein Subjected to 




phobicity	 analysis	 of	 TL1A	 shows	 a	 typical	 N-terminal	
peak	indicating	hydrophobic	amino	acids	that	can	be	in-

















































TL1A: A Novel Regulator of Cellular Senescence in 
Human Endothelial Cells
TL1A	mRNA	was	upregulated	in	human	CEP	from	old	






cultures.	 When	 full-length	 TL1A	 was	 overexpressed	 in	
young	HUVEC	or	CEP,	this	led	to	the	enlarged	phenotype	
typical	of	senescent	cells,	strong	staining	for	SA-b-gal,	an	







































mediated	 nuclear	 factor	 kappa	 B	 activation	 (66).	 The	
secretion	of	proinflammatory	IFN-g	was	stimulated	in	lam-
ina	propria	mononuclear	cells,	indicating	that	TL1A	may	
have	 a	 role	 in	 inflammatory	 bowel	 disease	 (26,29).	The	
TL1A	fragment	also	increased	IL-2	production	in	PBMCs	





















TL1AV84-L251,	 is	 generated	 by	 ectodomain	 shedding	 of	
membrane	bound	TL1A	(Figures	2	and	5A).	In	contrast	to	
TL1AL72-L251,	 the	 novel	 fragment	 induced	 apoptosis	 in	
HUVEC	(Figure	5C).	Indeed,	several	previous	reports	de-
scribed	 that	 artificially	 created	 fragments	 shorter	 than	
TL1AL72-L251	 can	 induce	 apoptosis	 in	 endothelial	 cells.	













the	 nomenclature	 of	 the	VEGI-174	 fragments	 is	 adapted	 	
to	 TL1A.	 The	 application	 of	 recombinant	 TL1AV101-L251	
(VEGIV24-L174)	led	to	the	time-	and	concentration-dependent	
apoptosis	 of	 endothelial	 cells	 (59,60).	 TL1AV102-L251	
(VEGIV25-L174)	also	markedly	inhibited	the	growth	of	endo-
















two	 fragments	 are	 probably	 produced	 via	ADAM17/10-	
mediated	alternative	cleavage	of	membrane	inserted	TL1A.	
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age?	What	causes	it	and	how	does	it	contribute	to	aging?	J Gerontol A 







human	cells	in	culture	and	in	aging	skin	in	vivo.	Proc Natl Acad Sci 
U S A.	1995;92:9363–9367.
	 5.	 Ressler	S,	Bartkova	J,	Niederegger	H,	et	al.	p16INK4A	is	a	robust	 	















Methusaleh’s	dilemma.	Am J Physiol Heart Circ Physiol.	2006;290:
H1729–H1739.
	 10.	 Campisi	J,	d’Adda	di	Fagagna	F.	Cellular	senescence:	when	bad	things	



































and	 TR6/DcR3	 and	 functions	 as	 a	 T	 cell	 costimulator.	 Immunity.	
2002;16:479–492.





TNF	ligand	family	member	TL1A	at	2.1A.	 Biochem  Biophys  Res 
Commun.	2007;364:1–6.
	 25.	 Al-Lamki	RS,	Wang	J,	Tolkovsky	AM,	et	al.	TL1A	both	promotes	and	















DR3,	 a	 death	 domain-containing	 receptor	 related	 to	 TNFR-1	 and	
CD95.	Science.	1996;274:990–992.
	 31.	 Screaton	 GR,	 Xu	 XN,	 Olsen	AL,	 et	 al.	 LARD:	 a	 new	 lymphoid-	
specific	death	domain	containing	receptor	regulated	by	alternative	pre-

















3-TNF-like	 protein	 1A	 pathway	 drives	 adverse	 bone	 pathology	 in	 	
inflammatory	arthritis.	J Exp Med.	2008;205:2457–2464.





































































Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai).	2000;32:
485–489.
	 61.	 Chomczynski	P,	Sacchi	N.	Single-step	method	of	RNA	isolation	by	
acid	 guanidinium	 thiocyanate-phenol-chloroform	 extraction.	 Anal 
Biochem.	1987;162:156–159.
	 62.	 Siebert	 PD,	 Chenchik	A.	 Modified	 acid	 guanidinium	 thiocyanate-	
phenol-chloroform	 RNA	 extraction	 method	 which	 greatly	 reduces	
DNA	contamination.	Nucleic Acids Res.	1993;21:2019–2020.
	 63.	 De	Matteis	MA,	Luini	A.	Exiting	the	Golgi	complex.	Nat Rev Mol 
Cell Biol.	2008;9:273–284.



















	 70.	 Zhang	 M,	Wang	 L,	Wang	 HW,	 Pan	 X,	 Pan	W,	 Qi	 ZT.	 [Effect	 of	 	
N-terminal	deletion	on	biological	activity	of	vascular	endothelial	cell	
growth	inhibitor].	Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 
(Shanghai).	2003;35:133–137.